Literature DB >> 2443142

Stereospecific action of diltiazem on the mitochondrial Na-Ca exchange system and on sarcolemmal Ca-channels.

M Chiesi, H Rogg, K Eichenberger, P Gazzotti, E Carafoli.   

Abstract

The benzothiazepine diltiazem is a potent Ca-channel blocker, which also inhibits the Na-dependent Ca-efflux from heart mitochondria. In this study, the action of the 4 stereoisomers of diltiazem has been investigated using guinea-pig heart and liver mitochondria. The rate of the Na-dependent Ca-efflux from liver mitochondria has been found to be 10 times smaller than in heart mitochondria. Otherwise, the exchange systems from the two tissues have been found to be pharmacologically indistinguishable. Both the (+)-optical isomers of the cis- and trans-forms of diltiazem inhibit Na-Ca exchange activity with comparable potency (IC50 of 10-20 microM), while the (-)-optical isomers are ineffective (IC50 greater than 200 microM). Radioligand binding experiments have revealed that only one stereoisomer of diltiazem, the (+)-cis form, interacts with high affinity with the Ca-channel receptors of guinea-pig heart sarcolemma preparations (KD = 120 nM). The results have shown that the Ca-channel of plasma membranes and the mitochondrial Na-Ca exchanger have different stereospecific requirements for the binding of diltiazem.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443142     DOI: 10.1016/0006-2952(87)90257-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

Review 1.  Characteristics and possible functions of mitochondrial Ca(2+) transport mechanisms.

Authors:  Thomas E Gunter; Shey-Shing Sheu
Journal:  Biochim Biophys Acta       Date:  2009-01-06

Review 2.  Transport of calcium by mitochondria.

Authors:  K K Gunter; T E Gunter
Journal:  J Bioenerg Biomembr       Date:  1994-10       Impact factor: 2.945

Review 3.  Calcium transport across the inner mitochondrial membrane: molecular mechanisms and pharmacology.

Authors:  György Csordás; Peter Várnai; Tünde Golenár; Shey-Shing Sheu; György Hajnóczky
Journal:  Mol Cell Endocrinol       Date:  2011-11-22       Impact factor: 4.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.